- Poster presentation
- Open Access
Rates of ventilator-associated pneumonia in critical care units in three Arabian Gulf countries; six-year surveillance study
© El-Saed et al; licensee BioMed Central Ltd. 2015
- Published: 16 June 2015
- Weight Group
- Critical Care Unit
- Gulf Cooperation Council
- ICUs Type
- Gulf Country
Data estimating the rates of ventilator-associated pneumonia (VAP) in critical patients in Gulf Cooperation Council (GCC) countries are either limited in some countries or completely lacking in other countries.
To estimate VAP rates in GCC hospitals and to compare such rates with published reports of US National Healthcare Safety Network (NHSN) and International Nosocomial Infection Control Consortium (INICC).
VAP rates and ventilator utilization between 2008 and 2013 were calculated from aggregated VAP surveillance data using NHSN methodology pooled from 6 hospitals in three GCC countries; Saudi Arabia, Oman, and Bahrain. Standardized infection ratio (SIR) of VAP in GCC hospitals were compared with published reports of NHSN and INICC.
A total 368 VAP events were diagnosed during 6 years of surveillance covering 76,749 ventilator days and 134,994 patient-days. The overall VAP rate was 4.8 per 1000 ventilator days (95% CI ranged between 4.3 and 5.3) with an overall ventilator utilization of 0.57. The VAP rates showed a wide variability between different types of intensive care units (ICUs) and were decreasing overtime. After adjusting for the differences in ICUs types in both sides, the risk of VAP in GCC hospitals was 217% higher than NHSN hospitals but 69% lower than INICC hospitals. Similarly, after adjusting for the differences in weight groups in neonatal ICUs in both sides, the risk of VAP in GCC hospitals was 69% higher than NHSN hospitals but 78% lower than INICC hospitals. Approximately 55% of the VAP events were diagnosed based on clinical criteria, which was very similar to published frequencies from similar ICUs in NHSN hospitals.
Current findings is considered the first regional VAP benchmark. The risk of VAP in adult and neonatal ICU patients in GCC countries is probably higher than the US but lower than many developing countries.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.